Position in CRMD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$204,915
-$159,743 QoQ
Shares Held
30,179
-3.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names. CRMD ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,200 | $58,503,546 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
58,925 | $45,527,812 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,859 | $35,025,567 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,684 | $29,330,533 | |
| 5 | RPRX |
Royalty Pharma plc
|
292,921 | $14,051,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
56,633 | $9,572,109 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
146,462 | $9,183,167 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
13,914 | $7,283,561 |
All Filings in CRMD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $204,915 | 30,179 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $364,658 | 31,355 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $360,530 | 31,000 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $344,960 | 28,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $179,490 | 29,138 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $236,017 | 29,138 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $158,141 | 19,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $82,867 | 19,138 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $81,145 | 19,138 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $71,958 | 19,138 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $70,810 | 19,138 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $144,460 | 36,388 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $80,762 | 19,138 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $54,160 | 19,138 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $76,934 | 19,138 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $77,476 | 14,138 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $71,152 | 15,638 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $65,741 | 14,138 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $96,986 | 14,138 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $141,238 | 14,138 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $121,391 | 16,338 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||